SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-213369
Filing Date
2024-09-04
Accepted
2024-09-04 20:45:40
Documents
1
Group Members
THIRD ROCK VENTURES GP IV, L.P.TRV GP IV, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d857596dsc13da.htm SC 13D/A 74447
  Complete submission text file 0001193125-24-213369.txt   76200
Mailing Address 29 NEWBURY STREET, 3RD FLOOR BOSTON MA 02116
Business Address 29 NEWBURY STREET, 3RD FLOOR BOSTON MA 02116 617-585-2000
Third Rock Ventures IV, L.P. (Filed by) CIK: 0001688327 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Subject) CIK: 0001819133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92241 | Film No.: 241279432
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)